IFF Sells Specialty Natural Ingredients Unit to SuanNutra, Closing Expected by Year-End
IFF sits 31% above its 52-week low of $59.14.
Summary
IFF is divesting a portfolio of specialty natural ingredients businesses to SuanNutra, a Carbyne Equity Partners portfolio company. The deal, expected to close by end of 2026 pending regulatory approvals, includes clinically supported branded ingredients, botanical extraction, fermented vitamins, and natural colors and flavors. This follows IFF's recent $4.3 billion sale of its Food Ingredients business to CVC Capital, signaling a continued strategic streamlining. Financial terms were not disclosed, but the transaction adds to IFF's ongoing portfolio reshaping. The combined SuanNutra entity will employ around 700 people across operations in Spain, Slovenia, Peru, and the U.S., serving over 1,200 customers in 60 countries.
At the time of this announcement, IFF was trading at $77.58 on NYSE in the Manufacturing sector, with a market capitalization of approximately $20B. The 52-week trading range was $59.14 to $84.45. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: PR Newswire.